Redox Stability Controls the Cellular Uptake and Activity of Ruthenium-Based Inhibitors of the Mitochondrial Calcium Uniporter (MCU).
Joshua J WoodsJames LovettBarry LaiHugh H HarrisJustin J WilsonPublished in: Angewandte Chemie (International ed. in English) (2020)
The mitochondrial calcium uniporter (MCU) is the ion channel that mediates Ca2+ uptake in mitochondria. Inhibitors of the MCU are valuable as potential therapeutic agents and tools to study mitochondrial Ca2+ . The best-known inhibitor of the MCU is the ruthenium compound Ru360. Although this compound is effective in permeabilized cells, it does not work in intact biological systems. We have recently reported the synthesis and characterization of Ru265, a complex that selectively inhibits the MCU in intact cells. Here, the physical and biological properties of Ru265 and Ru360 are described in detail. Using atomic absorption spectroscopy and X-ray fluorescence imaging, we show that Ru265 is transported by organic cation transporter 3 (OCT3) and taken up more effectively than Ru360. As an explanation for the poor cell uptake of Ru360, we show that Ru360 is deactivated by biological reductants. These data highlight how structural modifications in metal complexes can have profound effects on their biological activities.
Keyphrases
- energy transfer
- oxidative stress
- induced apoptosis
- fluorescence imaging
- cell cycle arrest
- photodynamic therapy
- physical activity
- mental health
- computed tomography
- cell death
- stem cells
- mesenchymal stem cells
- cell proliferation
- cell therapy
- deep learning
- mass spectrometry
- big data
- intellectual disability
- magnetic resonance